nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR1—umbilical vein—Kawasaki disease	0.187	0.227	CbGeAlD
Fingolimod—S1PR1—endothelium—Kawasaki disease	0.0885	0.108	CbGeAlD
Fingolimod—S1PR3—cardiac ventricle—Kawasaki disease	0.0667	0.0811	CbGeAlD
Fingolimod—Varicella—Acetylsalicylic acid—Kawasaki disease	0.0654	0.751	CcSEcCtD
Fingolimod—S1PR3—myocardium—Kawasaki disease	0.0627	0.0763	CbGeAlD
Fingolimod—S1PR4—heart—Kawasaki disease	0.0627	0.0763	CbGeAlD
Fingolimod—CYP4F12—cardiac ventricle—Kawasaki disease	0.0559	0.068	CbGeAlD
Fingolimod—CYP4F12—myocardium—Kawasaki disease	0.0525	0.0639	CbGeAlD
Fingolimod—S1PR5—skin of body—Kawasaki disease	0.0516	0.0628	CbGeAlD
Fingolimod—S1PR3—heart—Kawasaki disease	0.0438	0.0533	CbGeAlD
Fingolimod—S1PR1—heart—Kawasaki disease	0.0386	0.0469	CbGeAlD
Fingolimod—SPHK1—heart—Kawasaki disease	0.0382	0.0465	CbGeAlD
Fingolimod—SPHK1—skin of body—Kawasaki disease	0.0374	0.0455	CbGeAlD
Fingolimod—CYP4F12—heart—Kawasaki disease	0.0367	0.0446	CbGeAlD
Fingolimod—S1PR1—S1P1 pathway—VEGFA—Kawasaki disease	0.00792	0.0868	CbGpPWpGaD
Fingolimod—SPHK1—S1P1 pathway—VEGFA—Kawasaki disease	0.00701	0.0768	CbGpPWpGaD
Fingolimod—S1PR3—S1P3 pathway—VEGFA—Kawasaki disease	0.007	0.0767	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.0062	0.068	CbGpPWpGaD
Fingolimod—Influenza—Acetylsalicylic acid—Kawasaki disease	0.00555	0.0638	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.00549	0.0602	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—CCR5—Kawasaki disease	0.0046	0.0505	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.0044	0.0482	CbGpPWpGaD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—VEGFA—Kawasaki disease	0.00365	0.04	CbGpPWpGaD
Fingolimod—Leukopenia—Acetylsalicylic acid—Kawasaki disease	0.00346	0.0398	CcSEcCtD
Fingolimod—Hypertension—Acetylsalicylic acid—Kawasaki disease	0.00334	0.0384	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—ITPKC—Kawasaki disease	0.00304	0.0334	CbGpPWpGaD
Fingolimod—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	0.00282	0.0323	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ITPKC—Kawasaki disease	0.00263	0.0288	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CCR5—Kawasaki disease	0.00247	0.027	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CCR5—Kawasaki disease	0.00237	0.026	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CCR5—Kawasaki disease	0.00237	0.026	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ITPKC—Kawasaki disease	0.00226	0.0247	CbGpPWpGaD
Fingolimod—Pruritus—Acetylsalicylic acid—Kawasaki disease	0.00223	0.0257	CcSEcCtD
Fingolimod—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	0.00216	0.0248	CcSEcCtD
Fingolimod—S1PR1—G alpha (i) signalling events—CCR5—Kawasaki disease	0.00216	0.0236	CbGpPWpGaD
Fingolimod—Dizziness—Acetylsalicylic acid—Kawasaki disease	0.00209	0.024	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00196	0.0215	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00189	0.0207	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00189	0.0207	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.00176	0.0193	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00171	0.0188	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—VEGFA—Kawasaki disease	0.00166	0.0182	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CCR5—Kawasaki disease	0.00149	0.0164	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCR5—Kawasaki disease	0.00144	0.0158	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCR5—Kawasaki disease	0.00144	0.0158	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CCR5—Kawasaki disease	0.00131	0.0143	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CCR5—Kawasaki disease	0.000844	0.00925	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CCR5—Kawasaki disease	0.000812	0.0089	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCR5—Kawasaki disease	0.000812	0.0089	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CCR5—Kawasaki disease	0.000766	0.0084	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR5—Kawasaki disease	0.000738	0.00808	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR5—Kawasaki disease	0.000738	0.00808	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR5—Kawasaki disease	0.000738	0.00808	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCR5—Kawasaki disease	0.00067	0.00734	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCR5—Kawasaki disease	0.000453	0.00496	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR5—Kawasaki disease	0.000436	0.00478	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR5—Kawasaki disease	0.000436	0.00478	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR5—Kawasaki disease	0.000396	0.00434	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ITPKC—Kawasaki disease	0.000371	0.00406	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR5—Kawasaki disease	0.00035	0.00384	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ITPKC—Kawasaki disease	0.000263	0.00288	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—Kawasaki disease	0.000248	0.00271	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—Kawasaki disease	0.000238	0.00261	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—Kawasaki disease	0.000238	0.00261	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—Kawasaki disease	0.000222	0.00244	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—Kawasaki disease	0.000216	0.00237	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—Kawasaki disease	0.000214	0.00235	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—Kawasaki disease	0.000214	0.00235	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—Kawasaki disease	0.000194	0.00213	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—Kawasaki disease	0.000191	0.0021	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ITPKC—Kawasaki disease	0.000172	0.00188	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—Kawasaki disease	0.000172	0.00188	CbGpPWpGaD
